Predicting population coverage of T-cell epitope-based diagnostics and vaccines
Top Cited Papers
Open Access
- 17 March 2006
- journal article
- software
- Published by Springer Nature in BMC Bioinformatics
- Vol. 7 (1) , 1-5
- https://doi.org/10.1186/1471-2105-7-153
Abstract
Background: T cells recognize a complex between a specific major histocompatibility complex (MHC) molecule and a particular pathogen-derived epitope. A given epitope will elicit a response only in individuals that express an MHC molecule capable of binding that particular epitope. MHC molecules are extremely polymorphic and over a thousand different human MHC (HLA) alleles are known. A disproportionate amount of MHC polymorphism occurs in positions constituting the peptide-binding region, and as a result, MHC molecules exhibit a widely varying binding specificity. In the design of peptide-based vaccines and diagnostics, the issue of population coverage in relation to MHC polymorphism is further complicated by the fact that different HLA types are expressed at dramatically different frequencies in different ethnicities. Thus, without careful consideration, a vaccine or diagnostic with ethnically biased population coverage could result. Results: To address this issue, an algorithm was developed to calculate, on the basis of HLA genotypic frequencies, the fraction of individuals expected to respond to a given epitope set, diagnostic or vaccine. The population coverage estimates are based on MHC binding and/or T cell restriction data, although the tool can be utilized in a more general fashion. The algorithm was implemented as a web-application available at http://epitope.liai.org:8080/tools/population. Conclusion: We have developed a web-based tool to predict population coverage of T-cell epitope-based diagnostics and vaccines based on MHC binding and/or T cell restriction data. Accordingly, epitope-based vaccines or diagnostics can be designed to maximize population coverage, while minimizing complexity (that is, the number of different epitopes included in the diagnostic or vaccine), and also minimizing the variability of coverage obtained or projected in different ethnic groups.Keywords
This publication has 10 references indexed in Scilit:
- Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte EpitopesJournal of Virology, 2001
- Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopesImmunogenetics, 2001
- Ramifications of HLA class I polymorphism and population genetics for vaccine developmentGenetic Epidemiology, 2000
- HLA-DR-Promiscuous T Cell Epitopes fromPlasmodium falciparumPre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II AllelesThe Journal of Immunology, 2000
- HLA-binding peptides as a therapeutic approach for chronic HIV infection.2000
- HLA GENE AND HAPLOTYPE FREQUENCIES IN THE NORTH AMERICAN POPULATIONTransplantation, 1997
- Minimal phenotype panels: A method for achieving maximum population coverage with a minimum of HLA antigensHuman Immunology, 1996
- HLA allele selection for designing peptide vaccinesGenetic Analysis: Biomolecular Engineering, 1996
- HLA‐A, B Haplotype Frequencies in 5,202 Unrelated Danes by a Maximum‐Likelihood Method of Gene CountingTissue Antigens, 1979
- Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic systemNature, 1974